dr. gerds on design and safety analysis of a trial with luspatercept in myelofibrosis
Published 4 years ago • 58 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
1:19
dr. gerds on luspatercept to treat anemia in myelofibrosis
-
5:26
nct03194542 trial: luspatercept for the treatment of patients with anemic myelofibrosis
-
14:41
luspatercept compared with other available therapies for mf
-
7:18
how might luspatercept benefit patients with myelofibrosis?
-
8:08
luspatercept for the treatment of patients with anemic myelofibrosis: q&a session
-
2:26
ace-536-mf-001 update: luspatercept for the treatment of anemia in myelofibrosis
-
30:13
medical device patents with j.d. houvener and matt kulseth
-
5:13
my story | living with thalassemia
-
3:40
dr. jon resar
-
1:37
phase iii independence trial of luspatercept in patients with td myelofibrosis on jaki therapy
-
22:26
what's your approach? treating myelofibrosis
-
7:14
phase iii medalist trial of luspatercept for mds
-
4:20
treating anemia with luspatercept in mds
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
0:44
dr. patel on the clinical implications of luspatercept approval in mds
-
3:29
luspatercept in rbc transfusion-dependent mf patients
-
1:38
phase ii trial of luspatercept in myelofibrosis-associated anemia
-
2:15
independence: luspatercept vs placebo in mpns-associated myelofibrosis
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
2:14
trial updates for luspatercept in lr-mds: commands, medalist and elements-mds
-
4:00
real-world data on the efficacy of luspatercept in lr-mds
-
6:32
luspatercept reduces transfusion burden in mds-related anemia: medalist results